No Data
No Data
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Keybanc rai
HOOKIPA Pharma Is Maintained at Buy by HC Wainwright & Co.
HOOKIPA Pharma Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains HOOKIPA Pharma(HOOK.US) With Buy Rating, Raises Target Price to $6
H.C. Wainwright analyst Arthur He CFA maintains $HOOKIPA Pharma(HOOK.US)$ with a buy rating, and adjusts the target price from $5 to $6.According to TipRanks data, the analyst has a success rate of 53
Express News | HOOKIPA Pharma Inc. : H.c. Wainwright Raises Target Price to $6 From $5
HOOKIPA Pharma Announces Phase 2 Results For HB-200 Combined With Pembrolizumab In HPV16+ Head And Neck Cancer
Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated with HB-200 plus pembrolizumabIn a subset of 17 evaluable patients with PD-
Express News | HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
No Data